| |
AUC
|
95% CI of AUC
|
|---|
|
DAS28 w22
|
0.840
|
0.791–0.889
|
|
28 TJC w22
|
0.797
|
0.744–0.850
|
|
Physician global VAS w22
|
0.786
|
0.736–0.836
|
|
Patient pain VAS w22
|
0.764
|
0.71–0.814
|
|
DAS28 w14
|
0.750
|
0.685–0.815
|
|
Patient disease activity VAS w22
|
0.750
|
0.689–0.802
|
|
66TJC w22
|
0.740
|
0.689–0.791
|
|
28TJC w14
|
0.721
|
0.662–0.780
|
|
66SJC w22
|
0.717
|
0.660–0.774
|
|
ESR w22
|
0.716
|
0.654–0.779
|
| |
Sensitivity (%) at 95% specificity level
|
95% CI of sensitivity
|
|
DAS28 w22
|
42.5
|
36.9–48.1
|
|
Physician global VAS w22
|
32.7
|
28.4–37.0
|
|
28SJC w22
|
29.8
|
24.7–34.9
|
|
Patient pain VAS w22
|
26.8
|
22.7–30.9
|
|
66SJC w22
|
24.5
|
20.6–28.4
|
|
ESR w22
|
24.1
|
19.7–28.5
|
|
66SJC w14
|
23.0
|
18.6–27.4
|
|
CRP w22
|
21.3
|
17.3–25.3
|
|
Patient disease activity VAS w22
|
20.4
|
16.6-4.2
|
|
DAS28 w14
|
20.3
|
15.3–25.3
|
- AUC, area under the curve; TJC, tender joint count; SJC, swollen joint count; ESR, erythrocyte sedimentation rate; CI, confidence interval; CRP, C-reactive protein; w, week.
